Recent studies published in JAMA Network Open and the Journal of General Internal Medicine have highlighted significant findings regarding long COVID and its associated risks, particularly among women. Utilizing data from the NIH-funded RECOVER initiative, researchers discovered that women have a 31% higher risk of developing long COVID compared to men. This increased risk was most pronounced in women aged 40 to 54 and those aged 55 and older, while no heightened risk was noted in younger women aged 18 to 39. The study did not specifically address pregnancy's role in long COVID risk, but researchers suggested that immune changes during pregnancy might offer some protective benefits.
In a related investigation, the link between SARS-CoV-2 infections and the development of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) was explored. Among participants who had contracted SARS-CoV-2, 4.5% developed ME/CFS, compared to just 0.6% of those who remained uninfected. These findings suggest that ME/CFS may occur more frequently following a SARS-CoV-2 infection, adding it to a list of post-viral syndromes associated with other infections.
Both long COVID and ME/CFS are reported to be more common in women, leading researchers to consider potential shared underlying causes for these conditions, grouping them under the term "infection-associated chronic illnesses." Despite these insights, the exact causes of long COVID and ME/CFS remain unclear, and effective diagnostic tools and treatments are still lacking. Researchers, including Dr. Leora Horwitz, emphasize the urgent need for effective therapies for those suffering from long COVID and the importance of preventing its onset in others as future research continues.